In the current study, we have found that KLF15-/- mice are protected against HFD and ER stress-mediated steatosis and it is likely that increased AMPK activity in KLF15-/- liver contributes to this phenotype through inhibition of mTORC1 activity and induction of PGC-1α expression. The gene discussed is KLF15; the disease is steatosis.